The GenAI Divide: Beyond the 95% Failure Myth and the Workslop Epidemic
MIT revealed 95% of enterprises gain no ROI from GenAI—a headline that fuels skepticism but masks the deeper truth: the GenAI Divide. A small 5% capture massive value, while most drown in stalled pilots and workslop. Success hinges not on hype, but on governance and strategy.
This post is for paying subscribers only
Already have an account? Sign in.